CONTINUUS Pharmaceuticals
Boston
About CONTINUUS Pharmaceuticals
CONTINUUS Pharmaceuticals works with pharmaceutical and generic companies under a Build-Own-Operate model. They design, build, and run the manufacturing process directly at the client site. This novel business model provides its clients with an exceptional, ”one-shop solution” for their entire development and manufacturing cycle. CONTINUUS Pharmaceuticals is leveraging a novel continuous manufacturing platform called Integrated Continuous Manufacturing (ICM), initially developed through an $85 M joint research project between Novartis and MIT. In addition, the company is currently collaborating with hospital systems and pharmacy chains to establish its own generic business, where high-quality, low-cost drugs will be manufactured in the United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $9.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2019)
- Website: continuuspharma.com
- Phone: 6174176433
Industries & Categories
Biotechnology, Manufacturing, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/continuus-pharmaceuticals-20809 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.